Vol 11, No 4 (April 29, 2022): Translational Lung Cancer Research

Editorial

Will the ultra-low-dose intraoperative X-ray imager change thoracoscopic surgery?
Yoshikane Yamauchi
Translational Lung Cancer Research  
2022;
11
(4)
:506-508
.

Original Article

Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk
Rui Fu, Jia-Tao Zhang, Rong-Rong Chen, Hong Li, Zai-Xian Tai, Hao-Xiang Lin, Jian Su, Xiang-Peng Chu, Chao Zhang, Zhen-Bin Qiu, Zi-Hao Chen, Wen-Fang Tang, Song Dong, Xue-Ning Yang, Guo-Qing Zhang, Guo-Ping Zhao, Yi-Long Wu, Wen-Zhao Zhong
Translational Lung Cancer Research  
2022;
11
(4)
:509-522
.
Macrophages-based immune-related risk score model for relapse prediction in stage I–III non-small cell lung cancer assessed by multiplex immunofluorescence
Xiang-Rong Wu, Hao-Xin Peng, Miao He, Ran Zhong, Jun Liu, Yao-Kai Wen, Cai-Chen Li, Jian-Fu Li, Shan Xiong, Tao Yu, Hong-Bo Zheng, Yan-Hui Chen, Jian-Xing He, Wen-Hua Liang, Xiu-Yu Cai
Translational Lung Cancer Research  
2022;
11
(4)
:523-542
.
Picropodophyllin inhibits the growth of pemetrexed-resistant malignant pleural mesothelioma via microtubule inhibition and IGF-1R-, caspase-independent pathways
Rong Sun, Ryosuke Tanino, Xuexia Tong, Eshat Fahmida Haque, Yoshihiro Amano, Takeshi Isobe, Yukari Tsubata
Translational Lung Cancer Research  
2022;
11
(4)
:543-559
.
Role of radiomics in predicting lung cancer spread through air spaces in a heterogeneous dataset
Massimiliano Bassi, Andrea Russomando, Jacopo Vannucci, Andrea Ciardiello, Miriam Dolciami, Paolo Ricci, Angelina Pernazza, Giulia D’Amati, Carlo Mancini Terracciano, Riccardo Faccini, Sara Mantovani, Federico Venuta, Cecilia Voena, Marco Anile
Translational Lung Cancer Research  
2022;
11
(4)
:560-571
.
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma
Wei Guo, Qilin Huai, Tiejun Liu, Guochao Zhang, Naixin Liang, Qianli Ma, Xiang Liu, Fengwei Tan, Qi Xue, Shugeng Gao, Yibo Gao, Jie He
Translational Lung Cancer Research  
2022;
11
(4)
:572-587
.
Ultra-low-dose intraoperative X-ray imager for minimally invasive surgery: a pilot imaging study
Haewook Park, Kook Nam Han, Byeong Hyeon Choi, Hyunsuk Yoon, Hyun Joon An, Jae Sung Lee, Hyun Koo Kim
Translational Lung Cancer Research  
2022;
11
(4)
:588-599
.
Resection and reconstruction via median sternotomy incision for tracheal tumors
Jiaxi He, Chao Yang, Hanyu Yang, Hanzhang Chen, Jianxing He, Shuben Li
Translational Lung Cancer Research  
2022;
11
(4)
:600-606
.
A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer
Shuhui Cao, Yao Zhang, Yan Zhou, Wenwen Rong, Yue Wang, Xuxinyi Ling, Lincheng Zhang, Jingwen Li, Yusuke Tomita, Satoshi Watanabe, Takeo Nakada, Nobuhiko Seki, Toyoaki Hida, Said Dermime, Runbo Zhong, Hua Zhong
Translational Lung Cancer Research  
2022;
11
(4)
:607-616
.
Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients
Junnan Feng, Yan Li, Bing Wei, Lei Guo, Weihua Li, Qingxin Xia, Chengzhi Zhao, Jiawen Zheng, Jiuzhou Zhao, Rui Sun, Yongjun Guo, Luka Brcic, Taiki Hakozaki, Jianming Ying, Jie Ma
Translational Lung Cancer Research  
2022;
11
(4)
:617-631
.
Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma
Ninghua Yao, Ling Zuo, Xiaodi Yan, Jing Qian, Jie Sun, Huawei Xu, Feifei Zheng, Jimmy T. Efird, Izumi Kawagoe, Yan Wang, Sujie Ni
Translational Lung Cancer Research  
2022;
11
(4)
:632-646
.
The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study
Wenjuan Jiang, Yuling Zhou, Liang Zeng, Yi Xiong, Li Liu, Chunhua Zhou, Haiyan Yang, Hui Guo, Fabrizio Minervini, Stefano Bongiolatti, Nong Yang, Yongchang Zhang, Min Tao
Translational Lung Cancer Research  
2022;
11
(4)
:647-655
.
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases
Juan Zhou, Yinfei Wu, Mengqing Xie, Yujia Fang, Jing Zhao, Sung Yong Lee, Yunjoo Im, Lingyun Ye, Chunxia Su
Translational Lung Cancer Research  
2022;
11
(4)
:656-669
.
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk
Bing-Xi He, Yi-Fan Zhong, Yong-Bei Zhu, Jia-Jun Deng, Meng-Jie Fang, Yun-Lang She, Ting-Ting Wang, Yang Yang, Xi-Wen Sun, Lorenzo Belluomini, Satoshi Watanabe, Di Dong, Jie Tian, Dong Xie
Translational Lung Cancer Research  
2022;
11
(4)
:670-685
.

iMDT Corner

Osimertinib as induction therapy for oligometastatic non-small cell lung cancer with EGFR mutation: a case report
Han Wu, Junwei Ning, Ziming Li, Duilio Divisi, Antonio Rossi, Alessio Cortellini, Sang-Won Um, Yusuke Okuma, Chiara Lazzari, Qingquan Luo, Tianxiang Chen
Translational Lung Cancer Research  
2022;
11
(4)
:686-696
.

Editorial Commentary

Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon?
Wolfram C. M. Dempke, Klaus Fenchel, Susanne Reuther, Michael F. Murphy
Translational Lung Cancer Research  
2022;
11
(4)
:697-701
.